Back
Global X Emerging Markets Great Consumer ETF Vs. Halozyme Therapeutics, Inc. Industry Stock Comparison
Buy
54
EMC
Global X Emerging Markets Great Consumer ETF
Last Price:
$30.63
Seasonality Move:
1.22%
Buy
68
HALO
Halozyme Therapeutics, Inc.
Last Price:
$68.87
Seasonality Move:
5.49%
Buy
54
Global X Emerging Markets Great Consumer ETF (EMC)
is a Buy
Is Global X Emerging Markets Great Consumer ETF a Buy, Sell or Hold?
-
The current Global X Emerging Markets Great Consumer ETF [EMC] share price is $30.63. The Score for EMC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
EMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Halozyme Therapeutics, Inc. [HALO] share price is $68.41. The Score for HALO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EMC Stock Price Chart
What is Global X Emerging Markets Great Consumer ETF's stock price today?
-
The Global X Emerging Markets Great Consumer ETF share price today is $30.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EMC is experiencing slight selling pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics, Inc.'s stock price today?
-
The Halozyme Therapeutics, Inc. share price today is $68.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
EMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 55 | Buy |
| Chaikin Money Flow: | -14 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.83 - 30.57) | Buy |
| Bollinger Bands (100): | (29.79 - 31.21) | Buy |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 57.46 | Buy |
| Chaikin Money Flow: | -311112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.08 - 70.4) | Buy |
| Bollinger Bands (100): | (64.54 - 73.66) | Sell |
EMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.18 | Buy |
| 20-day SMA: | 30.32 | Buy |
| 50-day SMA: | 30.62 | Buy |
| 200-day SMA: | 29.05 | Buy |
| 8-day EMA: | 30.32 | Buy |
| 20-day EMA: | 30.32 | Buy |
| 50-day EMA: | 30.44 | Buy |
| 200-day EMA: | 29.39 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.39 | Buy |
| 20-day SMA: | 65.61 | Buy |
| 50-day SMA: | 67.14 | Buy |
| 200-day SMA: | 63.5 | Buy |
| 8-day EMA: | 66.77 | Buy |
| 20-day EMA: | 66.34 | Buy |
| 50-day EMA: | 67.11 | Buy |
| 200-day EMA: | 63.82 | Buy |
Global X Emerging Markets Great Consumer ETF Earnings Growth & EMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.13 per share, and an increase next year of $1.88 per share.
Global X Emerging Markets Great Consumer ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||